Thoughts?
anonymous Guest anonymous   Jun 16, 2018 at 05:52: PM #3 anonymous Guest at this point who really knows? Should’ve been killed long ago but here we are fresh off a renewal and somehow still here.
at this point who really knows? Should’ve been killed long ago but here we are fresh off a renewal and somehow still here.
anonymous Guest anonymous   Jun 16, 2018 at 07:19: PM #4 anonymous Guest They signed for another year. We should be good until end of 2019, unless...
anonymous Guest anonymous   Jun 16, 2018 at 09:25: PM #5 anonymous Guest anonymous said: It's dead!!! Click to expand... You wish
anonymous Guest anonymous   Jun 21, 2018 at 12:42: AM #6 anonymous Guest Crickets chirping.......
anonymous Guest anonymous   Jun 22, 2018 at 10:19: PM #7 anonymous Guest There is going to be more focus on primary care since Novartis is expecting to get the indication for diastolic HF in the near future. I don't think PDI is going anywhere......unless the indication doesn't happen.
There is going to be more focus on primary care since Novartis is expecting to get the indication for diastolic HF in the near future. I don't think PDI is going anywhere......unless the indication doesn't happen.
anonymous Guest anonymous   Jun 23, 2018 at 12:06: PM #8 anonymous Guest The thing that's going nowhere at the moment is sales growth.
anonymous Guest anonymous   Jun 25, 2018 at 12:31: AM #9 anonymous Guest anonymous said: The thing that's going nowhere at the moment is sales growth. Click to expand... Why do you think sales are so flat?
anonymous said: The thing that's going nowhere at the moment is sales growth. Click to expand... Why do you think sales are so flat?
anonymous Guest anonymous   Jun 25, 2018 at 12:34: AM #10 anonymous Guest You must not be on Entresto Sales Force to not know why sales are flat